TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biovica International AB
Closing information (x1000 EUR)
| Closing information | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Turnover |
786
|
620
|
299 |
| Financial expenses |
104
|
25
|
44 |
| Earnings before taxes |
-7,837
|
-10,562
|
-9,775 |
| EBITDA |
-7,018
|
-9,990
|
-9,030 |
| Total assets |
5,920
|
11,181
|
15,216 |
| Current assets |
2,807
|
7,497
|
10,597 |
| Current liabilities |
1,655
|
2,407
|
2,088 |
| Equity capital |
3,938
|
8,223
|
12,244 |
| - share capital |
594
|
477
|
269 |
| Employees (average) |
26
|
37
|
31 |
Financial ratios
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Solvency |
66.5%
|
73.5%
|
80.5% |
| Turnover per employee |
30
|
17
|
10 |
| Profit as a percentage of turnover |
-997.1%
|
-1703.5%
|
-3269.2% |
| Return on assets (ROA) |
-130.6%
|
-94.2%
|
-64.0% |
| Current ratio |
169.6%
|
311.5%
|
507.5% |
| Return on equity (ROE) |
-199.0%
|
-128.4%
|
-79.8% |
| Change turnover |
121
|
332
|
118 |
| Change turnover % |
18%
|
115%
|
65% |
| Chg. No. of employees |
-11
|
6
|
6 |
| Chg. No. of employees % |
-30%
|
19%
|
24% |
Total value of public sale
| Fiscal year | 2025/04 (consolidated) | 2024/04 (consolidated) | 2023/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.